Eli Lilly and Company (LLY) Stock Price & AI Analysis

$884.54
$24.85
(2.89%)
Pharmaceuticals

NYSE USA

April 27, 4:25 PM EDT
  • Market Cap.
    838.53B
  • Volume
    3.39M
  • Avg. Volume
    3.66M
  • Target Price
    $1,024.93
  • 52W Range
    677.09 - 972.53
  • RSI (14)
    63.47
  • Beta
    0.48
  • PEG Ratio
    1.83
  • SMA 20
    12.24%
  • SMA 50
    6.20%
  • SMA 200
    4.63%
  • Insider Owner
    10.34%
  • Insider Trans
    -0.89%
  • Institution Owner
    73.02%
  • Institution Trans
    -5.53%
  • Short Interest
    7.02%
  • EPS next Y
    33.32

Eli Lilly and Company Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm’s products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm’s products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Eli Lilly and Company | Latest news

Is Eli Lilly and Company (LLY) the Best Stock That Will Always Grow?

We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going...

Insider Monkey - 4 days ago

Eli Lilly (LLY) Stands Firm Amid Tariff Concerns

Eli Lilly (LLY) and Novo Nordisk remain resilient amid potential new pharmaceutical tariffs. Analysts foresee a 14.87% potential upside for Eli Lilly, with

Guru Focus - 1 day ago

Is Eli Lilly and Company (LLY) the Best Stock to Invest in for Long Term?

We recently published a list of 10 Best Stocks to Invest in for Long Term. In this article, we are...

Insider Monkey - 2 days ago

Analysts Maintain Buy Ratings on Eli Lilly Stock (LLY) as Q1 Earnings Loom

Eli Lilly (LLY) is scheduled to release its Q1 earnings on May 1, and analysts continue to stay...

TipRanks - 2 days ago

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

Eli Lilly's stock surges as its investigational oral GLP-1 pill, orforglipron, achieves the primary...

Zacks - 6 days ago

Eli Lilly (LLY) Files Lawsuits Against Compounders Over Tirzepatide Copies | LLY...

Eli Lilly and Co. (LLY, Financial) has initiated legal action against four companies accused of selling unauthorized versions of its medication containing tirzepatide. This move follows a recent ...

Guru Focus - 4 days ago

Eli Lilly and Company (LLY): Among the Best American Dividend Stocks to Buy...

We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts....

Insider Monkey - 6 days ago

Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's...

Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings...

Zacks - 3 days ago

Forget Zepbound: Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Eli Lilly (NYSE: LLY) has been growing its sales at a good clip over the past year. This is partly...

Motley Fool - 4 days ago

Eli Lilly Will Be the Next $1 Trillion Stock

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first...

247wallstcom - 2 days ago